Asia-Pacific Pneumococcal Disease Control in the Pneumococcal Conjugate Vaccine Era

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1196415

Funding Status
Status not available

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Pneumonia is one of the commonest causes of childhood death worldwide. PCV is a vaccine that prevents pneumonia but it is costly; and causes an increase in disease from strains which are not in the vaccine. Our CRE will address 2 outstanding issues: when to switch from a 3 to 2 dose PCV schedule to make it more affordable; and create new understanding of the non-vaccine strains’ impact on disease in low- and middle-income countries in the Asia-Pacific region.

Funded Activity Details

Start Date: 01-01-2020

End Date: End date not available

Funding Scheme: Centres of Research Excellence

Funding Amount: $2,500,000.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

health economics | pneumococcal vaccination | respiratory diseases | vaccination immunology

Related Links